icon3

Pain Management Devices Market: By Type (Ablation Devices, Analgesic Infusion Pumps, Others) By Mode of Purchase ( Prescription-based Devices and Over-the-counter Devices) By Application (Musculoskeletal Pain, Facial Pain & Migraine, Cancer Pain and Neuropathic Pain) Regional Analysis & Forecast - 2026

  • OI-132
  • |
  • Published date: Jun, 2019
  • |
  • Medical Devices
  • |
  • 120 Pages

Introduction


Pain Management is a stream of medical sciences that eases the suffering of patients who have chronic pain. Pain is managed by a particular set of drugs or devices to treat pain. Most of these devices block the pain gate mechanism, to block the passage of pain signals to the brain. In addition, Pain management devices help to reduce the risk of long-term narcotics, non-steroidal anti-inflammatory drugs, and other pain-relieving medications.


Market Overview


The Global Pain Management Devices Market was valued at $ XX Mn in 2018 and is forecast to grow at a XX% CAGR between 2018 and 2026, resulting in 2026 global sales of $ XX. The market is driven by owing large patient population base and rising demand for long-term pain management among the geriatric population. However, low awareness about the availability and use of pain management devices are restraining the market growth. Moreover, a robust product pipeline for pain management devices is providing ample opportunities for market


Pain Management Devices depending on the type, Prescription-based Devices segment is expected to account for the largest share of the due to the longer market presence of these devices with established safety and efficacy profiles and their long-term cost-effectiveness.


Key Developments



  • NeuroMetrix, in 2018 launched Quell 2.0, a 100% drug-free device that can be really effective in managing pains. Quell app has also been designed to make its operational facilities simple. The product is also smaller in size.


Segmentation


The Global Pain Management Devices market is segmented on the basis of type, mode of purchase, application, and region.


Based on the Type: Ablation Devices, Analgesic Infusion Pumps, and Neurostimulation Devices.


Based on the Mode of Purchase: Prescription-based Devices and Over-the-counter Devices.


Based on the Application: Musculoskeletal Pain, Facial Pain & Migraine, Cancer Pain and Neuropathic Pain.


Based on the Region: North America, Asia-Pacific, Europe, and LAMEA. Among that Asia-Pacific held the largest share of the market due to the increasing incidence of chronic diseases, growing government support, and increasing middle-class population and disposable income levels in this region are a factor to drive the regional growth.


The key players of the Global Pain Management Devices Market are Becton, Dickinson and Company, Smiths Medical, Hospira, Inc., Boston Scientific Corporation, Neurotech Na, Inc., Medtronic PLC, Stryker Corporation, Pfizer, DJO Global LLC, Codman and Shurtleff, Baxter International and NeuroMetrix

The report covers in-depth analysis of the Global Pain Management Devices Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and In approval), By Type (Minimally Invasive Surgical Devices, Non-Invasive Surgical Devices). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.


The report includes in-depth company profiles of key players in the Global Pain Management Devices Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.


The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.


Scope:



  • Provides a detailed analysis of the market structure along with the forecast of the various segments and sub-segments of the Global Pain Management Devices Market.

  • Provides a comparative analysis of key marketed and pipeline products

  • Provides key information on players involved in the Pain Management Devices Market.

  • Provides a complete overview of market segments and the regional outlook of Global Pain Management Devices Market.

  • Provides in-depth coverage of key news related to Global Pain Management Devices Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates

Our research works on a holistic 360° approach to deliver high quality, validated and reliable information in our market reports. Market estimation and forecasting involve the following steps:




  • Data Collation (Primary & Secondary)




  • In-house Estimation (Based on proprietary databases and Models)




  • Market Triangulation




  • Forecasting




  • Market-related information is assembled from both primary and secondary sources. 








  • Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. 








  • Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others. 








  • Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.





REPORT YOU MIGHT BE INTERESTED

Choose Licence Type

$3,850.00
$4,950.00


(For Corporate Licence Only) Complementary
Credit card Logo
Inquiry Before Buying

Related Reports


Contact Us

Email Us at: sales@optimainsights.org | Reach Us at: +91 966 6620 365 | +1 424 2554 365 (US)